VANGILOK Trademark

Trademark Overview


On Wednesday, May 15, 2013, a trademark application was filed for VANGILOK with the United States Patent and Trademark Office. The USPTO has given the VANGILOK trademark a serial number of 85932379. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 12, 2015. This trademark is owned by Agouron Pharmaceuticals, Inc.. The VANGILOK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
vangilok

General Information


Serial Number85932379
Word MarkVANGILOK
Filing DateWednesday, May 15, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 12, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 24, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAgouron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAgouron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, January 12, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 12, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 2, 2014EXTENSION 1 GRANTED
Monday, June 9, 2014EXTENSION 1 FILED
Tuesday, July 1, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 9, 2014TEAS EXTENSION RECEIVED
Tuesday, December 10, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 5, 2013ASSIGNED TO EXAMINER
Tuesday, September 3, 2013ASSIGNED TO EXAMINER
Friday, May 24, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 18, 2013NEW APPLICATION ENTERED IN TRAM